Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.25.1 (
deoxyribonuclease
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The 3' --> 5'-exonucleases process DNA ends in many DNA repair pathways of human cells. Determination of the human
TREX2
structure is the first of a dimeric 3'-
deoxyribonuclease
and indicates how this highly efficient nonprocessive enzyme removes nucleotides at DNA 3' termini. Symmetry in the
TREX2
dimer positions the active sites at opposite outer edges providing open access for the DNA. Adjacent to each active site is a flexible region containing three arginines positioned appropriately to bind DNA and to control its entry into the active site. Mutation of these three arginines to alanines reduces the DNA binding capacity by approximately 100-fold with no effect on catalysis. The human
TREX2
catalytic residues overlay with the bacterial DnaQ family of 3'-exonucleases confirming the structural conservation of the catalytic sites despite limited sequence identity, and mutations of these residues decrease the still measurable activity by approximately 10(5)-fold, confirming their catalytic role.
...
PMID:The human TREX2 3' -> 5'-exonuclease structure suggests a mechanism for efficient nonprocessive DNA catalysis. 1566 38
The activity of human
TREX2
-catalyzed 3' --> 5'-
deoxyribonuclease
has been analyzed in steady-state and single turnover kinetic assays and in equilibrium DNA binding studies. These kinetic data provide evidence for cooperative DNA binding within
TREX2
and for coordinated catalysis between the
TREX2
active sites supporting a model for communication between the protomers of a
TREX2
dimer. Mobile loops positioned adjacent to the active sites provide the major DNA binding contribution and facilitate subsequent binding into the active sites. Mutations of three arginine residues on these loops cause decreased
TREX2
activities by up to 60-fold. Steady-state kinetic assays of these arginine to alanine
TREX2
variants result in increased K(m) values for DNA substrate with no effect on k(cat) values indicating contributions exclusively to DNA binding by all three of the loop arginines.
TREX2
heterodimers were prepared to determine whether exonuclease activity in one protomer is communicated to the opposing protomer. Evidence for communication across the dimer interface is provided by the 7-fold lower catalytic activity measured in the
TREX2
(WT/H188A) heterodimer compared with the
TREX2
(WT) homodimer, contrasting the 2-fold lower activity measured in the
TREX2
(WT/R163A,R165A,R167A) heterodimer. The measured activity in
TREX2
(WT/H188A) heterodimer indicates that defective catalysis in one protomer reduces activity in the opposing protomer. A DNA binding analysis of
TREX2
and the heterodimers indicates a cooperative binding effect within the
TREX2
protomer. Finally, single turnover kinetic assays identify DNA binding as the rate-limiting step in
TREX2
catalysis.
...
PMID:Cooperative DNA binding and communication across the dimer interface in the TREX2 3' --> 5'-exonuclease. 1853 78